|
IVA
|
Inventiva S.A.
|
US
|
NASDAQ
|
|
ME
|
23andMe Holding Co.
|
US
|
NASDAQ
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
NEO
|
NeoGenomics, Inc.
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NVTA
|
Invitae Corporation
|
US
|
NYSE
|
|
OSUR
|
OraSure Technologies, Inc.
|
US
|
NASDAQ
|
|
QTNT
|
Quotient Limited
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
US
|
NASDAQ
|
|
RGLS
|
Regulus Therapeutics Inc.
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
US
|
NASDAQ
|
|
RPTX
|
Repare Therapeutics Inc.
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
US
|
NASDAQ
|
|
SOPH
|
Sophia Genetics SA
|
US
|
NASDAQ
|
|
SVA
|
Sinovac Biotech, Ltd. (Antigua/Barbudo)
|
US
|
NASDAQ
|
|
TNGX
|
Tango Therapeutics
|
US
|
NASDAQ
|
|
VYGR
|
Voyager Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DNAG
|
Dnaprint Genomics
|
US
|
OTC
|
|
GMPXF
|
Gmp Capital Inc
|
US
|
OTC
|
|
GSGTF
|
Gensight Biologics Sa
|
US
|
OTC
|